Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTeam17 Regulatory News (TM17)

Share Price Information for Team17 (TM17)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 270.00
Bid: 265.00
Ask: 275.00
Change: -2.50 (-0.93%)
Spread: 10.00 (3.774%)
Open: 267.50
High: 273.00
Low: 265.00
Prev. Close: 267.50
TM17 Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

21 Sep 2023 13:06

RNS Number : 2546N
Team17 Group PLC
21 September 2023
 

21 September 2023

Team17 Group plc

("Team17" or the "Company")

 

Director / PDMR Shareholding

 

Team17, a global games label, creative partner, developer and publisher of independent ("indie") premium video games, educational entertainment apps for children and working simulation games, announces that it has received notification from Peter Whiting, a Non-Executive Director of the Company, that on 20 September 2023 he purchased 20,900 ordinary shares of £0.01 each in the Company ("Ordinary Shares") at a price of 308.9 pence per Ordinary Share

 

Following this purchase, Mr Whiting's interest in Ordinary Shares is as follows:

 

Name

No. of Ordinary Shares

% of issued Ordinary Shares

Peter Whiting

20,900

0.014%

 

The Company publicly discloses the following notifications pursuant to the EU Market Abuse Regulations:

 

1.

Details of the Person discharging managerial responsibilities ("PDMR") / person closely associated with them ("PCA")

a)

Name

Mr Peter Whiting

2.

Reason for the notification

a)

Position / status

PDMR (Non-Executive Director)

b)

Initial notification / amendment

Initial notification

 

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Team17 Group plc

 

b)

Legal Entity Identifier

2138006EUUCCL4ZI5E51

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary shares of £0.01 each in the Company ("Ordinary Shares")ISIN: GB00BYVX2X20

 

b)

Nature of the transaction

Purchase of Ordinary Shares

 

c)

Price(s) and volume(s)

20,900 Ordinary Shares purchased at a price of 308.9p per Ordinary Share

 

d)

Aggregated information

·  Aggregated volume

·  Aggregated price

NA

e)

Date of the transaction(s)

20 September 2023

 

f)

Place of the transaction

AIMX

 

 

Enquiries:

Team17 Group plc

Debbie Bestwick MBE, Chief Executive Officer

Steve Bell, Chief Executive Officer Designate

Mark Crawford, Chief Financial Officer

James Targett, Group Investor Relations Director

 

Via Vigo Consulting

 

Houlihan Lokey (Nominated Adviser)

Adrian Reed / Tim Richardson

 

+44 (0) 161 250 3577

 

Berenberg (Joint Broker)

Toby Flaux / Ben Wright / Marie Moy / Alix Mecklenburg-Solodkoff

 

+44 (0) 20 3207 7800

Peel Hunt (Joint Broker)

Neil Patel / Paul Gillam / Richard Chambers / James Smith

 

+44 (0) 20 7418 8900

Vigo Consulting (Financial Public Relations)

Jeremy Garcia / Fiona Hetherington / Kate Kilgallen

team17@vigoconsulting.com

 

+44 (0) 20 7390 0233

 

About Team17

 

Team17 Group plc is a global provider of games entertainment to a broad audience. The Group now includes a games entertainment label and creative partner for indie developers, a leading developer of educational apps, targeting children under the age of eight and a leading working simulation games developer and publisher.

 

Visit www.team17.com for more info.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHNKDBKBBKDPCB
Date   Source Headline
13th Mar 20239:05 amRNSNo Material Exposure to Silicon Valley Bank
2nd Mar 20237:00 amRNSNotice of Results & Analyst/Investor Presentations
13th Feb 20231:41 pmRNSDirector/PDMR Shareholding
31st Jan 20232:40 pmRNSHoldings in Company
19th Jan 20235:20 pmRNSHolding(s) in Company
18th Jan 20237:00 amRNSTrading Update
12th Jan 20239:04 amRNSDirector/PDMR Shareholding
10th Jan 20236:19 pmRNSHolding(s) in Company
9th Jan 20232:48 pmRNSTrading Update
13th Dec 20223:51 pmRNSDirector/PDMR Shareholding
17th Nov 20228:46 amRNSHolding(s) in Company
11th Nov 20225:13 pmRNSDirector/PDMR Shareholding
20th Oct 202212:11 pmRNSHolding(s) in Company
18th Oct 20221:42 pmRNSDirector/PDMR Shareholding
13th Sep 20224:32 pmRNSDirector/PDMR Shareholding
13th Sep 20227:00 amRNSHalf Year Results
5th Sep 20227:00 amRNSNotice of Results & Analyst/Investor presentations
12th Aug 20221:29 pmRNSDirector/PDMR Shareholding
18th Jul 20225:08 pmRNSHolding(s) in Company
15th Jul 20223:25 pmRNSHolding(s) in Company
14th Jul 20227:00 amRNSTrading Update
12th Jul 20223:56 pmRNSDirector/PDMR Shareholding
30th Jun 20223:58 pmRNSGrant of Options to Directors / PDMRs
29th Jun 20224:39 pmRNSResult of AGM
15th Jun 20227:00 amRNSDirector/PDMR Shareholding
14th Jun 20221:26 pmRNSHolding(s) in Company
1st Jun 202212:00 pmRNSPosting of Annual Report and Notice of AGM
20th May 20221:28 pmRNSDirector/PDMR Shareholding
17th May 20221:22 pmRNSDirector / PDMR Shareholding & Total Voting Rights
11th May 20225:36 pmRNSDirector/PDMR Shareholding
12th Apr 20225:48 pmRNSDirector/PDMR Shareholding
5th Apr 202211:06 amRNSSecond Price Monitoring Extn
5th Apr 202211:00 amRNSPrice Monitoring Extension
30th Mar 20227:00 amRNSUnaudited Final Results
28th Mar 20224:40 pmRNSSecond Price Monitoring Extn
28th Mar 20224:35 pmRNSPrice Monitoring Extension
28th Mar 20227:00 amRNSInvestor / Analyst call
11th Mar 20223:19 pmRNSDirector/PDMR Shareholding
8th Mar 20224:41 pmRNSSecond Price Monitoring Extn
8th Mar 20224:36 pmRNSPrice Monitoring Extension
1st Mar 20227:00 amRNSNotice of Results
14th Feb 20223:59 pmRNSHolding(s) in Company
11th Feb 20222:21 pmRNSDirector/PDMR Shareholding
1st Feb 20221:00 pmRNSDirector/PDMR Shareholding
20th Jan 20222:45 pmRNSHolding(s) in Company
18th Jan 20221:56 pmRNSDirector/PDMR shareholding
14th Jan 202212:40 pmRNSDirector/PDMR Shareholding
14th Jan 20227:00 amRNSResults of Placing
13th Jan 20224:36 pmRNSProposed Placing of New Ordinary Shares
13th Jan 20224:35 pmRNSEUR100m acquisition of astragon

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.